Apex Labs Expands Macrodose Psilocybin PTSD Trial
Apex Labs Ltd. received approval from Israel’s Ministry of Health to expand its phase 2b clinical trial, SUMMIT-90, for...
eClinical Tech News
Atai & Beckley Psychedelic Merger Creates Global Mental Health Leader
Atai Life Sciences and Beckley Psytech are merging in an all-stock transaction, creating atai Beckley, a leading mental health...
Humacyte’s AV Access Study Shows Promising Results
Humacyte, a biotech company focused on bioengineered human tissues, presented positive Phase 3 clinical trial results for their acellular...
Metsera Announces Positive Phase 1 Data of Amylin Candidate
Metsera, Inc. announced positive Phase 1 clinical trial data for MET-233i, a new ultra-long-acting amylin analog designed for monthly...
Ziftomenib Monotherapy Shows Positive Pivotal Data at ASCO 2025
Kura Oncology and Kyowa Kirin announced positive Phase 2 trial results for ziftomenib, an oral menin inhibitor, in patients...
4D Path Biomarker Predicts Breast Cancer Treatment Response
4D Path presented groundbreaking findings at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting, demonstrating that their...
Amtagvi® Five-Year Analysis in Advanced Melanoma: Journal of Clinical Oncology
Iovance Biotherapeutics announced five-year follow-up results from the Phase 2 C-144-01 trial of its T cell therapy, Amtagvi (lifileucel),...
ISB 2001 Shows High Response Rates in Relapsed/Refractory Multiple Myeloma
Ichnos Glenmark Innovation (IGI) presented positive Phase 1 trial data for ISB 2001, a novel trispecific antibody targeting BCMA,...
Rosnilimab Shows Positive Phase 2b Results in RA Trial
AnaptysBio’s investigational drug, rosnilimab, has shown promising results in a Phase 2b trial for rheumatoid arthritisarthritis (RA). The drug...
Akeega® Improves Efficacy in HRR-Mutated mHSPC
Johnson & Johnson’s Phase 3 AMPLITUDE study demonstrates that the combination of niraparib and abiraterone acetate with prednisone significantly...